Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.
Vaccine trials were undertaken to determine whether the Fel-O-Vax FIV, a commercial dual-subtype (subtypes A and D) feline immunodeficiency virus (FIV) vaccine, is effective against a subtype B FIV isolate. Current results demonstrate the Fel-O-Vax FIV to be effective against a subtype B virus, a subtype reported to be the most common in the USA.
Pu
Ruiyu
R
Department of Pathobiology, College of Veterinary Medicine, University of Florida, P.O. Box 110880, Gainesville, FL 32611-0880, USA.
Coleman
James
J
Coisman
James
J
Sato
Eiji
E
Tanabe
Taishi
T
Arai
Maki
M
Yamamoto
Janet K
JK
D000818:Animals; D002415:Cats; D016181:Feline Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000517:prevention & control*; D016089:Immunodeficiency Virus, Feline / Q000235:genetics / Q000276:immunology*; D015164:Vaccines, Inactivated / Q000276:immunology; D014730:Veterinary Medicine; D014765:Viral Vaccines / Q000276:immunology*
D015164:Vaccines, Inactivated; D014765:Viral Vaccines